Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.

NCT07717450 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

370

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Invasive Breast Cancer

Interventions

PROCEDURE: Tumor assessment
OTHER: Completion of Quality-of-life questionnaires
PROCEDURE: ECG
PROCEDURE: Visual Acuity assessment

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]
[object Object]